Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-18-002045
Filing Date
2018-02-22
Accepted
2018-02-22 16:03:56
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adms1231201710k.htm 10-K 2055946
2 EXHIBIT 10.37 adms10k2017ex1037.htm EX-10.37 41484
3 EXHIBIT 10.38 adms10k2017ex1038.htm EX-10.38 163833
4 EXHIBIT 23.1 adms10k2017ex231.htm EX-23.1 2803
5 EXHIBIT 31.1 adms10k2017ex311.htm EX-31.1 14033
6 EXHIBIT 31.2 adms10k2017ex312.htm EX-31.2 13942
7 EXHIBIT 32.1 adms10k2017ex321.htm EX-32.1 8472
14 exhibitca01.jpg GRAPHIC 131185
15 exhibitd.jpg GRAPHIC 104776
16 newpremises2.jpg GRAPHIC 27372
17 newpremises.jpg GRAPHIC 28285
18 portfolio.jpg GRAPHIC 73041
19 stockgraph2.jpg GRAPHIC 87772
  Complete submission text file 0001628280-18-002045.txt   9466930

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT adms-20171231.xml EX-101.INS 1701382
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20171231.xsd EX-101.SCH 55817
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20171231_cal.xml EX-101.CAL 89319
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20171231_def.xml EX-101.DEF 307568
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20171231_lab.xml EX-101.LAB 815488
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20171231_pre.xml EX-101.PRE 489699
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36399 | Film No.: 18632507
SIC: 2834 Pharmaceutical Preparations